Tenax Therapeutics, Inc.

US$1.69As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:TENXHealthcare
Country USA
PE (Fwd) •••
TSR 10Y CAGR (64.27%)
Div yield —
ROE (64.20%)
Biotechnology
Beta (5Y) 0.97
PE TTM —
TSR TTM (76.98%)
Mkt cap US$96.81M
ROIC (42.43%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$1.88
11.27%
(70.95%)
Hold 5|10|8|8|6
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.02
0.02
0.02
0.02
2.42%
9.41%
19.87%
24.98%
Revenue$M
11.04
10.82
10.97
11.40
8.09%
5.01%
6.07%
4.46%
Peers (US$96.81M)
Cap (US$)
PE
96.40M
—
Capital
TTM
5Y
10Y
Leveragex
1.204
0.889
0.669
EBIT/Intx
0.802
0.043
0.043
Own earn%
(323.79)
(6.18)
(20.87)
Sh yield%
8.95
28.74
27.04
Owners
Insiders/Inst%
8.06
75.49
Short interest%
1.67
SBC / revenue%
3.86
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
1
Op margin range%
10–14
$1 testx
0.0
Incr. ROIC%
2